Literature DB >> 7640205

The molecular detection of circulating tumour cells.

P W Johnson1, S A Burchill, P J Selby.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7640205      PMCID： PMC2033986          DOI： 10.1038/bjc.1995.324

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  114 in total

1.  A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow.

Authors:  A Molino; M Colombatti; F Bonetti; M Zardini; F Pasini; A Perini; G Pelosi; G Tridente; D Veneri; G L Cetto
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

2.  Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high-dose chemotherapy.

Authors:  F Dreyfus; J Melle; M C Quarre; C Pillier
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

3.  The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus.

Authors:  H de Thé; C Chomienne; M Lanotte; L Degos; A Dejean
Journal:  Nature       Date:  1990-10-11       Impact factor: 49.962

4.  Interferon-alpha 2b in the treatment of follicular lymphoma: preliminary results of a trial in progress.

Authors:  C G Price; A Z Rohatiner; W Steward; D Deakin; N Bailey; A Norton; G Blackledge; D Crowther; T A Lister
Journal:  Ann Oncol       Date:  1991-02       Impact factor: 32.976

5.  The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.

Authors:  S P Hunger; N Galili; A J Carroll; W M Crist; M P Link; M L Cleary
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

6.  Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.

Authors:  M P Osborne; G Y Wong; S Asina; L J Old; R J Cote; P P Rosen
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

7.  Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4 Eo.

Authors:  J G Dauwerse; J W Wessels; R H Giles; J Wiegant; B A van der Reijden; G Fugazza; E A Jumelet; E Smit; F Baas; A K Raap
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

8.  Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remission.

Authors:  D Diverio; P P Pandolfi; A Biondi; G Avvisati; M C Petti; F Mandelli; G Pelicci; F Lo Coco
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

9.  Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse.

Authors:  T P Hughes; G J Morgan; P Martiat; J M Goldman
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

10.  Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia.

Authors:  Q Chen; C Y Yang; J T Tsan; Y Xia; A H Ragab; S C Peiper; A Carroll; R Baer
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307
View more
  35 in total

1.  Increased detection rate and potential prognostic impact of disseminated tumor cells in patients undergoing endorectal ultrasound for rectal cancer.

Authors:  Moritz Koch; Dalibor Antolovic; Peter Kienle; Johanna Horstmann; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Int J Colorectal Dis       Date:  2006-06-07       Impact factor: 2.571

2.  A strategy to identify genes associated with circulating solid tumor cell survival in peripheral blood.

Authors:  M V Fournier; M G Carvalho; A B Pardee
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

Review 3.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

4.  Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastases.

Authors:  Moritz Koch; Peter Kienle; Ulf Hinz; Dalibor Antolovic; Jan Schmidt; Christian Herfarth; Magnus von Knebel Doeberitz; Jürgen Weitz
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

5.  Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue.

Authors:  F A Vlems; J H S Diepstra; I M H A Cornelissen; T J M Ruers; M J L Ligtenberg; C J A Punt; J H J M van Krieken; Th Wobbes; G N P van Muijen
Journal:  Mol Pathol       Date:  2002-06

6.  Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.

Authors:  D Van der Velde-Zimmermann; J F Roijers; A Bouwens-Rombouts; R A De Weger; P W De Graaf; M G Tilanus; J G Van den Tweel
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

7.  Detection of circulating melanoma cells by immunomagnetic cell sorting.

Authors:  A Benez; A Geiselhart; R Handgretinger; U Schiebel; G Fierlbeck
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

8.  Comparison of the RNA-amplification based methods RT-PCR and NASBA for the detection of circulating tumour cells.

Authors:  S A Burchill; L Perebolte; C Johnston; B Top; P Selby
Journal:  Br J Cancer       Date:  2002-01-07       Impact factor: 7.640

9.  Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer.

Authors:  M Koch; P Kienle; P Sauer; F Willeke; K Buhl; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz; J Weitz
Journal:  Surg Endosc       Date:  2004-01-23       Impact factor: 4.584

10.  Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation: a first step towards a molecular surrogate marker for neoadjuvant treatment in colorectal cancer.

Authors:  Peter Kienle; Moritz Koch; Frank Autschbach; Axel Benner; Martina Treiber; Michael Wannenmacher; Magnus von Knebel Doeberitz; Markus Büchler; Christian Herfarth; Jürgen Weitz
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.